China Medical GatewayLoading your healthcare gateway…

Beijing Puxiang Eye Hospital

Beijing Puxiang Eye Hospital — Beijing

Hospital Profile

Beijing Puxiang Ophthalmology Hospital is affiliated with the Puxiang Group (founded in 2004) and is located in Zhongguancun, Haidian District, Beijing, covering a total area of over 4,000 square meters. The hospital is a specialized hospital focused on ophthalmology, achieving full coverage of ophthalmic services. In the industry, it is known as the 'Little Tongren' and is praised by patients as 'your nearby ophthalmologist.' Its key advantages lie in leveraging a team of top-tier experts and cutting-edge international equipment to build a full-cycle myopia grading diagnosis and treatment and eye health service loop of 'prevention-control-intervention.' For challenges such as pathological myopia in children and high myopia fundus repair, it provides a one-stop, non-overmedicalized, refined diagnosis and treatment plan.

Medical Milestones

• 2004: The parent company, Puxiang Group, was established, beginning to deeply cultivate the eye health business. • September 2026: The hospital publicly released the latest diagnosis and treatment system and core technological achievements, showcasing tens of thousands of successful cases of its fiber optic-guided minimally invasive posterior scleral reinforcement surgery (such as vision salvage and eye axis obstruction for children with ultra-high myopia of 1700 degrees/2100 degrees and complex monocular patients).

Key Capabilities & Patient Care

• Core Competencies: Full-cycle vision health management and treatment of complex eye diseases. This includes four major areas: pediatric pathological myopia prevention, high myopia fundus repair, complex vitreoretinal surgery, and traumatic eye preservation, as well as retinal detachment, complex cataracts, pediatric strabismus and amblyopia, among others. The hospital has a multidisciplinary expert team led by Chief Ophthalmologist Feng Kang from the former Peking University Third Hospital Fundus Surgery Department (a protégé of Professor Ma Zhizhong), along with a resident physician team headed by three directors: Zhen Jing, Gao Yuwei, and Chen Jianhua. It also collaborates with top-tier experts from institutions such as Tongren, Peking Union Medical College Hospital, Beijing Children's Hospital, and Peking University Third Hospital (including Duan Anli, Yun Bo, Zhang Shuxin, and others) for regular consultations.

Advanced Technology

Core technologies and patents include the fiber-optic-guided minimally invasive posterior scleral reinforcement surgery (utilizing real-time infrared fiber-optic positioning, implantation error within 0.2mm, 5mm minimally invasive incision), fiber-optic-guided posterior scleral buckle reinforcement surgery, among others. Director Feng Kang holds 8 utility model patents for ophthalmic minimally invasive surgeries. In addition, Beijing Puxiang Hospital is equipped with 6 Class 100 laminar flow operating rooms; it possesses internationally advanced ophthalmic diagnostic and treatment equipment such as high-definition OCT, ultra-widefield fundus camera, femtosecond laser equipment, and offers inpatient beds. Data statistics: • Bed capacity: Inpatient beds available; inpatient ward and beds, 24-hour on-duty nursing (2026); total area over 4,000 ㎡ • Number of departments: Full coverage in refractive (full femtosecond/ICL), cataract, fundus disease/fundus surgery, pediatric ophthalmology/strabismus and amblyopia, ocular trauma, myopia prevention and control • Number of full-time physicians: Not disclosed (resident physician team led by three directors: Zhen Jing, Gao Yuwei, Chen Jianhua) • Multi-site practice/specially invited experts: Total number not disclosed; regular joint consultations with experts from Tongren, Xiehe, Beijing Children's Hospital, Peking University Third Hospital: Duan Anli, Yun Bo, Zhang Shuxin, etc.; Director Feng Kang (former backbone of fundus surgery at Peking University Third Hospital, national vitrectomy training instructor) as the core expert • Annual outpatient visits: Not disclosed • Surgical capability: Fiber-optic-guided minimally invasive posterior scleral reinforcement surgery cumulatively over ten thousand cases (2026); Feng Kang holds 8 utility model patents for ophthalmic minimally invasive surgeries; 6 Class 100 laminar flow operating rooms (2026); high-definition OCT, femtosecond laser equipment • International certification and qualifications: Parent group Puxiang Group established in 2004; approved by Haidian District Health Commission, Beijing • International services: Not detailed

International Patient Services

• Support online consultations, remote rehabilitation guidance, and multidisciplinary team (MDT) joint consultations for patients from other regions and across regions. • Provide full-process dedicated customer service connection, in-depth explanation of the condition, and a seamless after-sales follow-up mechanism (not explicitly mentioning direct payment of foreign medical insurance or the establishment of an international department).

Return to Home